|70.38||-0.6100||-0.86%||Vol 150.91K||1Y Perf 51.30%|
|Apr 19th, 2021 13:56 DELAYED|
|- -%||- -|
|Target Price||85.80||Analyst Rating||Strong Buy 1.33|
|Potential %||21.65||Finscreener Ranking||★★ 47.07|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★ 39.61|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★★ 58.76|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Market Cap||5.84B||Earnings Rating||Strong Sell|
|Price Range Ratio 52W %||52.40||Earnings Date||1st Jun 2021|
Today's Price Range
5 Year PE Ratio Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||1st Jun 2021|
|Estimated EPS Next Report||0.19|
|EPS Growth Next 5 Years %||12.80|
|Avg. Weekly Volume||355.32K|
|Avg. Monthly Volume||550.00K|
|Avg. Quarterly Volume||897.10K|
HealthEquity Inc. (NASDAQ: HQY) stock closed at 70.99 per share at the end of the most recent trading day (a 1.4% change compared to the prior day closing price) with a volume of 284.84K shares and market capitalization of 5.84B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 2931 people. HealthEquity Inc. CEO is Jon Kessler.
The one-year performance of HealthEquity Inc. stock is 51.3%, while year-to-date (YTD) performance is 1.84%. HQY stock has a five-year performance of 182.49%. Its 52-week range is between 45.13 and 93.32, which gives HQY stock a 52-week price range ratio of 52.40%
HealthEquity Inc. currently has a PE ratio of 572.70, a price-to-book (PB) ratio of 4.07, a price-to-sale (PS) ratio of 7.88, a price to cashflow ratio of 28.10, a PEG ratio of 2.32, a ROA of 0.32%, a ROC of 1.29% and a ROE of 0.71%. The company’s profit margin is 1.20%, its EBITDA margin is 21.40%, and its revenue ttm is $733.57 Million , which makes it $8.84 revenue per share.
Of the last four earnings reports from HealthEquity Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.19 for the next earnings report. HealthEquity Inc.’s next earnings report date is 01st Jun 2021.
The consensus rating of Wall Street analysts for HealthEquity Inc. is Strong Buy (1.33), with a target price of $85.8, which is +21.65% compared to the current price. The earnings rating for HealthEquity Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
HealthEquity Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
HealthEquity Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 11.16, ATR14 : 3.62, CCI20 : 89.07, Chaikin Money Flow : -0.12, MACD : -2.84, Money Flow Index : 49.95, ROC : 5.96, RSI : 45.53, STOCH (14,3) : 91.79, STOCH RSI : 1.00, UO : 52.91, Williams %R : -8.21), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of HealthEquity Inc. in the last 12-months were: Angelique Hill (Option Excercise at a value of $94 650), Angelique Hill (Sold 11 091 shares of value $729 125 ), Ashley Dreier (Option Excercise at a value of $395 850), Ashley Dreier (Sold 16 250 shares of value $975 000 ), Darcy G. Mott (Option Excercise at a value of $560 000), Darcy G. Mott (Sold 24 000 shares of value $1 800 050 ), Delano Ladd (Option Excercise at a value of $1 553 268), Delano Ladd (Sold 55 000 shares of value $4 691 773 ), Frank A. Corvino (Option Excercise at a value of $57 820), Frank A. Corvino (Sold 7 403 shares of value $561 079 ), Frank T. Medici (Option Excercise at a value of $319 050), Frank T. Medici (Sold 10 148 shares of value $710 182 ), Jon Kessler (Sold 250 000 shares of value $19 043 571 ), Larry L Trittschuh (Option Excercise at a value of $382 825), Larry L Trittschuh (Sold 8 283 shares of value $585 399 ), William Robert Otten (Sold 1 925 shares of value $125 125 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.